Inside the research
MetLife, Inc.
MET Research profile · latest available data
Price overview
$97.70
▲ +0.45 (+0.5%)
| 52w hi | $99.95 |
|---|---|
| 52w lo | $66.77 |
| Vol | 3.63M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.41
| Short | +0.58 |
|---|---|
| Medium | +0.37 |
| Long | +0.12 |
computed 2026-09-27
Key fundamentals
MetLife, Inc.
Financial Services · Insurance - Life
| Market cap | $62.09B |
|---|---|
| Enterprise value | $85.60B |
| Trailing P/E | 18.72x |
| Forward P/E | 8.94x |
| EV / EBITDA | 14.17x |
| P / S (ttm) | 0.78x |
| Profit margin | 4.6% |
| Return on equity | 13.1% |
| Revenue growth | +10.5% |
| Earnings growth | +5.8% |
| Debt / equity | 179.93 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.21 | |
| Sector | +0.02 | |
| Technical | +0.25 | |
| Earnings | +0.00 | |
| Sentiment | +0.24 |
macro × 1.00 · 2026-09-27
Business overview
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
Risk Metrics
| Beta vs SPX | 1.00 |
|---|---|
| Corr SPX | 0.61 |
| Annual vol | 26.4% |
| Annual ret | +13.0% |
| Sharpe | 0.49 |
| Max DD | -23.3% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $90.25 |
|---|---|
| High / Low | $106.00 / $75.00 |
| Median | $90.50 |
| Analysts | 16 |
| Strong Buy | 4 | |
|---|---|---|
| Buy | 8 | |
| Hold | 6 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-07 | Barclays | → Overweight |
| 2026-04-14 | B of A Securities | → Buy |
| 2026-04-13 | Mizuho | → Outperform |
| 2026-04-10 | Wells Fargo | → Overweight |
| 2026-04-09 | UBS | → Buy |
| 2026-04-09 | Evercore ISI Group | → In-Line |
Officers & Board
| Director | Carla A. Harris since 2022 |
|---|---|
| Director | Mark Weinberger since 2019 |
| Director | Michel Khalaf since 2019 |
| Director | Gerald Hassell since 2018 |
| Director | Diana McKenzie since 2018 |
| Director | David Herzog since 2016 |
| Director | Ned Kelly since 2015 |
| Director | Denise Morrison since 2014 |
| Director | William Kennard since 2013 |
| Director | Carlos Gutierrez since 2013 |
| Director | Catherine Kinney since 2009 |
| Director | Glenn Hubbard since 2007 |
| Director | Cheryl Grisé since 2004 |
| CEO | Steven A. Kandarian current |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-05 | Earnings Release, Reg FD Disclosure… | read |
| 2026-06-29 | Reg FD Disclosure | read |
| 2026-06-22 | Shareholder Vote | read |
| 2026-05-15 | Other Material Event, Exhibits | read |
| 2026-05-06 | Earnings Release, Reg FD Disclosure… | read |
| 2026-04-07 | Reg FD Disclosure | read |
| 2026-03-05 | Other Material Event, Exhibits | read |
| 2026-02-26 | Material Obligation, Other Material Event… | read |
| 2026-02-24 | Officer / Director Change | read |
| 2026-02-17 | Other Material Event, Exhibits | read |
| 2026-02-04 | Earnings Release, Reg FD Disclosure… | read |
| 2026-01-09 | Reg FD Disclosure, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Mumenthaler Christian Stephane | Grant | 587 | $51.30K | |
| 2026-06-16 | Kennard William E | Grant | 587 | $51.30K | |
| 2026-06-16 | Johnson Jeh C. | Grant | 587 | $51.30K | |
| 2026-06-16 | MCKENZIE DIANA | Grant | 587 | $51.30K | |
| 2026-06-16 | Hay Laura J | Grant | 587 | $51.30K | |
| 2026-06-16 | HUBBARD ROBERT GLENN | Grant | 1.02K | $88.80K | |
| 2026-06-16 | Harris Carla A | Grant | 587 | $51.30K | |
| 2026-06-16 | Seitz Michelle | Grant | 587 | — | |
| 2026-06-16 | Glaser Daniel S | Grant | 587 | $51.30K | |
| 2026-06-16 | WEINBERGER MARK A | Grant | 587 | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 97.4% |
| HHI | 4,870 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $2.14B | 25.34M |
| AQR Capital Management | $348.79M | 4.12M |
| Capital Research / Capital World | $222.60M | 2.63M |
| Citadel Advisors | $185.27M | 2.19M |
| Fidelity / FMR LLC | $166.54M | 1.97M |
| Bridgewater Associates | $52.59M | 621.52K |
| Millennium Management | $28.50M | 336.85K |
| T. Rowe Price Group | $1.80M | 21.28M |
As of 2026-06-30
Connections
Subsidiarys: PineBridge Investments
Dividends
| Yield (TTM) | 1.16% |
|---|---|
| $ / share (TTM) | $1.14 |
| 5y CAGR | +4.3% |
Annual dividend per share
| 2021 | $1.90 |
|---|---|
| 2022 | $1.98 |
| 2023 | $2.06 |
| 2024 | $2.15 |
| 2025 | $2.25 |
| 2026 | $0.57 |
Federal Contracts
| Amount | Agency | Description |
|---|---|---|
| $2.98M | Department of State | HEALTH AND LIFE INSURANCE |
| $2.81M | Department of State | HEALTH AND LIFE INSURANCE |
| $2.51M | Department of State | HEALTH AND LIFE INSURANCE |
| $1.81M | Department of State | HEALTH AND LIFE INSURANCE |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.23B | -17.4% | |
| Operating income | $6.00B | +0.0% | |
| Net income | $1.58B | -4.6% | |
| Cash from ops | $17.09B | +3.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $97.54 | $98.45 | $96.67 | $97.70 | 3.63M |
| Sep 24 | $97.73 | $98.18 | $97.06 | $97.25 | 3.44M |
| Sep 23 | $95.20 | $97.67 | $95.01 | $97.20 | 2.94M |
| Sep 22 | $97.47 | $98.00 | $95.03 | $95.92 | 2.64M |
| Sep 21 | $97.44 | $97.84 | $96.54 | $96.64 | 1.93M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →